两株人肺癌细胞摄取99Tcm-MIBI的比较
Comparison of the Uptake of 99Tcm-MIBI in Two Lung Cancer Cell Lines
-
摘要: 比较2株人肺癌细胞对亲肿瘤显像剂99TcmMIBI的不同摄取特征。细胞摄取 99Tcm-MIBI的动力学行为显示99Tcm-MIBI在小细胞肺癌(H446)中的摄取显著高于肺腺癌（SPC-1），H446细胞对99Tcm-MIBI的摄取在120 min内逐渐升高至最大峰值，然后缓慢下降；此摄取可被未标记的MIBI所抑制；H446细胞对99Tcm-MIBI的摄取与细胞数量呈正相关而与放射性浓度呈负相关；SPC-1细胞对 99Tcm-MIBI的摄取处于低水平状态，无明显峰值。结果显示，不同的肺癌细胞具有对99Tcm-MIBI的不同摄取特性，这与临床不同类型肺癌患者的99Tcm-MIBI显像结果不同相符。
-
关键词:
- 人肺癌细胞 /
- 99Tcm-MIBI /
- 细胞摄取
Abstract: The uptake characters of 99Tcm-MIBI in two lung cancer cell lines (human small cell lung cancer H446 cells and human lung adenocarcinoma SPC-1 cells) were investigated. The uptake kinetic data show that H446 cells absorb significantly higher level of 99Tcm-MIBI comparing with SPC-1 cells. The uptake percentage of 99Tcm-MIBI in H446 cells increases time-dependently and reaches its peak value at about 120 min, and then droppes slowly. This uptake in H446 cells is positively correlated with the number of cells while negatively with the concentration of radiolabelled 99Tcm-MIBI. Furthermore, it is markedly inhibited by excessive unlabelled MIBI. However, the uptake of 99Tcm-MIBI in SPC-1 cells maintains at low levels without a visible peak during the experiment time. These results suggest that the uptake characters of 99Tcm-MIBI are different in two lung cancer cell lines, which is accordant with the clinical facts that patients with lung cancers displayed diverse 99Tcm-MIBI imaging patterns.-
Keywords:
- human lung cancer cell lines /
- 99Tcm-MIBI /
- cellular uptake
-
-
[1] Jones A G, Abrams M J, Davison A, et al. Biological Studies of a New Class of Technetium Complexes: the Hexakis(Alkylisonitrile)Technetium(Ⅰ) Cations[J]. Int J Nucl Med Biol, 1984, 11（3-4）: 225-234. [2] Muller S T, Guth T B, Creutzig H. Imaging of Malignant Tumor With 99Tcm-MIBI SPECT[J]. J Nucl Med, 1987, 28（4）: 562. [3] Vecchio S D, Zannetti A, Salvatore B, et al. Functional Imaging of Multidrug Resistance in Breast Cancer[J]. Phys Med, 2006, 21(Suppl 1): 24-27. [4] Pui M H, Du J Q, Yueh T C, et al. Imaging of Nasopharyngeal Carcinoma With Tc-99m MIBI[J]. Clin Nucl Med, 1998, 23（1）: 29-32. [5] Akgun A, Cok G, Karapolat I, et al. Tc-99m MIBI SPECT in Prediction of Prognosis in Patients With Small Cell Lung Cancer[J]. Ann Nucl Med, 2006, 20（4）: 269-275. [6] 朱爱芝,陈丽蓉,郭秋菊,等. 99Tcm-MIBI 和 99Tcm-tetrofosmin 在肿瘤细胞的摄取和在荷瘤小鼠体内的分布[J].核化学与放射化学,2000, 22（4）: 215-221. [7] Shih C M, Hsu W H, Huang W T, et al. Usefulness of Chest Single Photon Emission Computed Tomography With Technetium-99m Methoxyisobutylisonitrile to Predict Taxol Based Chemotherapy Response in Advanced Non-Small Cell Lung Cancer[J]. Cancer Lett, 2003, 199（1）: 99-105. [8] Moretti J L, Hauet N, Caglar M, et al. To Use MIBI or not to Use MIBI？ That is the Question When Assessing Tumour Cells[J]. Eur J Nucl Med Mol Imaging, 2005, 32（7）: 836-842. [9] Ballinger J R. Experimental and Clinical Observations of 99Tcm-MIBI Uptake Correlate With P-Glycoprotein Expression in Lung Cancer[J]. Nucl Med Commun, 2008, 29（3）: 303. [10] Yuksel M, Cermik T F, Doganay L, et al. 99Tcm-MIBI SPET in Non-Small Cell Lung Cancer in Relationship With Pgp and Prognosis[J]. Eur J Nucl Med Mol Imaging, 2002, 29（7）: 876-881.
计量
- 文章访问数: 1333
- HTML全文浏览量: 0
- PDF下载量: 2556
下载:
